RA CAPITAL MANAGEMENT, L.P. bought MLYS
March 30, 2026 · Form 4 insider transaction
RA CAPITAL MANAGEMENT, L.P. bought 58,300 shares of Mineralys Therapeutics, Inc. at $24.16 per share, a transaction worth $1.41M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.88 to $24.39 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.; Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund").; RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.